Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study

American Heart Journal

Volumn 166, Issue 5, 2013, Pages 913-919

  Bagai, Akshay ^a   Armstrong, Paul W ^b   Stebbins, Amanda ^a   Mahaffey, Kenneth W ^a   Hochman, Judith S ^c   Weaver, W Douglas ^d   Patel, Manesh R ^a   Granger, Christopher B ^a   Lopes, Renato D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEXELIZUMAB; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; FEMALE; HAZARD RATIO; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SINGLE-CHAIN ANTIBODIES; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84886949270     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.08.006     Document Type: Article

References (27)

1. L.D. Hillis, and E. Braunwald Myocardial ischemia (first of three parts) N Engl J Med 296 1977 971 978
2. A. Halkin, G.W. Stone, and S.R. Dixon Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction Am J Cardiol 96 2005 325 331
3. R.J. Burns, R.J. Gibbons, and Q. Yi The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis J Am Coll Cardiol 39 2002 30 36
4. M.J. Kern, and T. Christopher Hemodynamic rounds series II: the LVEDP Cathet Cardiovasc Diagn 44 1998 70 74
5. A. Bergstra, T. Svilaas, and D.J. van Veldhuisen Haemodynamic patterns in ST-elevation myocardial infarction: incidence and correlates of elevated filling pressures Neth Heart J 15 2007 95 99
6. P.L. Van Herck, S.G. Carlier, and M.J. Claeys Coronary microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure Heart 93 2007 1231 1237
7. D. Planer, R. Mehran, and B. Witzenbichler Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 108 2011 1068 1074
8. P.W. Armstrong, and C.B. Granger Pexelizumab and the APEX AMI trial JAMA 297 2007 1881
9. P.W. Armstrong, P.X. Adams, and H.R. Al-Khalidi Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention Am Heart J 149 2005 402 407
10. A. Stebbins, R.H. Mehta, and P.W. Armstrong A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial Circ Cardiovasc Interv 3 2010 414 422
11. M. St John Sutton Quest for diastolic prognostic indicators of clinical outcome after acute myocardial infarction Circulation 117 2008 2570 2572
12. J.S. Forrester, G. Diamond, and W.W. Parmley Early increase in left ventricular compliance after myocardial infarction J Clin Invest 51 1972 598 603
13. J.E. Moller, P.A. Pellikka, and G.S. Hillis Prognostic importance of diastolic function and filling pressure in patients with acute myocardial infarction Circulation 114 2006 438 444
14. G.S. Hillis, J.E. Moller, and P.A. Pellikka Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction J Am Coll Cardiol 43 2004 360 367
15. G. Cerisano, L. Bolognese, and P. Buonamici Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction J Am Coll Cardiol 37 2001 793 799
16. J.E. Moller, G.A. Whalley, and F.L. Dini Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: Meta-Analysis Research Group in Echocardiography Acute Myocardial Infarction Circulation 117 2008 2591 2598
17. M. Shanks, A.C. Ng, and N.R. van de Veire Incremental prognostic value of novel left ventricular diastolic indexes for prediction of clinical outcome in patients with ST-elevation myocardial infarction Am J Cardiol 105 2010 592 597
18. A.J. Kirtane, A. Bui, and S.A. Murphy Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction J Thromb Thrombolysis 17 2004 177 184
19. R. Teixeira, C. Lourenco, and R. Baptista Prognostic implications of left ventricular end-diastolic pressure in acute coronary syndromes with left ventricular ejection fraction of 40% or over Rev Port Cardiol 30 2011 771 779
20. M.J. Claeys, J. Bosmans, and L. Veenstra Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome Circulation 99 1999 1972 1977
21. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988
22. T.E. Raya, R.G. Gay, and L. Lancaster Serial changes in left ventricular relaxation and chamber stiffness after large myocardial infarction in rats Circulation 77 1988 1424 1431
23. A. Popovic, N. Neskovic, and J. Marinkovic Serial assessment of left ventricular chamber stiffness after acute myocardial infarction Am J Cardiol 77 1996 361 364
24. M. Remmelink, K.D. Sjauw, and J.P. Henriques Acute left ventricular dynamic effects of primary percutaneous coronary intervention from occlusion to reperfusion J Am Coll Cardiol 53 2009 1498 1502
25. O. Satiroglu, Y. Cicek, and M. Bostan Acute change in left ventricle end-diastolic pressure after primary percutaneous coronary intervention in patients with ST segment elevation myocardial infarction Am Heart Hosp J 8 2010 E86 E90
26. S. van Diepen, L.K. Newby, and R.D. Lopes Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy Int J Cardiol 2013 10.1016/j.ijcard.2013.01.004 [Epub ahead of print]
27. J.A. Ezekowitz, P. Theroux, and W. Chang N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction Can J Cardiol 22 2006 393 397